Our data showed that TNF-α-upregulated FTMT expression was inhibited by an NF-κB inhibitor, BAY 11-7082, similar to our previous study using IMR-32 neuroblastoma cells [28]. The gene discussed is NFKB1; the disease is neuroblastoma.